1. Mansouri, Alireza, Hachem, Laureen D, Mansouri, Sheila, Aldape, Kenneth D, Zadeh, Gelareh. . MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges. In Neuro-oncology, 21, 167-178. doi:10.1093/neuonc/noy132. https://pubmed.ncbi.nlm.nih.gov/30189035/
2. Della Monica, Rosa, Cuomo, Mariella, Visconti, Roberta, Tafuto, Salvatore, Chiariotti, Lorenzo. 2021. Evaluation of MGMT Gene Methylation in Neuroendocrine Neoplasms. In Oncology research, 28, 837-845. doi:10.3727/096504021X16214197880808. https://pubmed.ncbi.nlm.nih.gov/34016221/
3. Bacolod, Manny D, Barany, Francis. . MGMT Epigenetics: The Influence of Gene Body Methylation and Other Insights Derived from Integrated Methylomic, Transcriptomic, and Chromatin Analyses in Various Cancer Types. In Current cancer drug targets, 21, 360-374. doi:10.2174/1568009621666210203111620. https://pubmed.ncbi.nlm.nih.gov/33535955/
4. Chen, Bizheng, Ying, Xiaozhen, Bao, Liming. 2021. MGMT gene promoter methylation in humoral tissue as biomarker for lung cancer diagnosis: An update meta-analysis. In Thoracic cancer, 12, 3194-3200. doi:10.1111/1759-7714.14186. https://pubmed.ncbi.nlm.nih.gov/34651448/
5. Philteos, Justine, Karmur, Brij S, Mansouri, Alireza. . MGMT Testing in Glioblastomas: Pitfalls and Opportunities. In American journal of clinical oncology, 42, 117-122. doi:10.1097/COC.0000000000000490. https://pubmed.ncbi.nlm.nih.gov/30444735/